Opening book details…
Can I read Kinase Inhibitor Drugs (Wiley Series in Drug Discovery and Development) on EtoBox?
Kinase Inhibitor Drugs (Wiley Series in Drug Discovery and Development) by Rongshi Li, Ph. D.; Jeffrey A Stafford is a nonfiction available to read on EtoBox.
What is Kinase Inhibitor Drugs (Wiley Series in Drug Discovery and Development) about?
<p><P><b>A comprehensive resource on case studies of marketed kinase drugs and promising drug trials</b> <P>Since the discovery of protein kinase activity in 1954, the field of protein kinase drug discovery has advanced dramatically. With the ongoing clinical success of the Bcr-Abl kinase inhibitor Gleevec in the treatment of chronic myelogenous leukemia and seven additional marketed kinase inhibitor drugs, researchers have compelling evidence that kinase inhibitors can be highly efficacious in the treatment of diseases caused by aberrant activity of protein kinase. Currently more than 100 protein kinase inhibitors are in clinical development. <P>In one comprehensive volume, the editors, Dr. Rongshi Li and Dr. Jeffrey Stafford, present timely and important case studies of marketed kinase drugs and several of the most advanced kinase inhibitors in clinical trials. <i>Kinase Inhibitor Drugs</i> includes:<P><ul><P><li> Case studies from leading investigators and experts in the field that provide firsthand accounts of kinase inhibitor discovery<P><li> Current thinking on kinase structure, biochemistry, and signal transduction pathways<P><li> Information on state-of-the-art technolo
Who reads Kinase Inhibitor Drugs (Wiley Series in Drug Discovery and Development)?
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Rongshi Li, Ph. D.; Jeffrey A Stafford
- Publisher
- Wiley & Sons, Incorporated, John
- Published
- 2009
- Language
- EN
- ISBN
- 9780470278291
- Category
- nonfiction
- Subjects
- Medical, Pharmacology, Medicine
Other editions & translations
More by Rongshi Li, Ph. D.; Jeffrey A Stafford
Browse all works by Rongshi Li, Ph. D.; Jeffrey A Stafford
Similar books
- Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development) — Mark Pearson PhD, Carlos García-Echeverría PhD (auth.), Doriano Fabbro PhD, Frank McCormick MD, (2006)
- Drug-Drug Interactions in Pharmaceutical Development (Wiley Series in Drug Discovery and Development) — Binghe Wang; Albert P. Li (2007)
- Drug Discovery and Development Volume 1 - Drug Discovery – Wiley-Interscience — Chorghade M.S., , (2006) (2006)
- Carbon Monoxide in Drug Discovery: Basics, Pharmacology, and Therapeutic Potential (Wiley Series in Drug Discovery and Development) — Leo E. Otterbein , Binghe Wang (2022)
- ABC Transporters and Multidrug Resistance (Wiley Series in Drug Discovery and Development) — Ahcène Boumendjel; Jean Boutonnat; Jacques Robert (2009)
- Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, Metabolism, Pharmaceutics, and Toxicology (Wiley Series in Drug Discovery and Development) — Chao Han, Charles B. Davis, Binghe Wang, Binghe PhD (2009)
